There are 2 reasons why BTA appeals - and one is the exact point mentioned in the AFR article - that relenza still has legs and lani is lined up ready to be the next big thing.
The other reason is that BTA typically goes up disproportionately in the northern hemisphere flu season and gives the opportunity to sell at an inflated price and and re-buy when reality sets in.
I'm hoping this current rise in SP will give me the third opportunity to do this in three years.
NEU is a blatant speccy. The thought that a drug could have a positive effect on people with severe brain trauma appeals.
BTA Price at posting:
$1.15 Sentiment: Hold Disclosure: Held
